Live from the NIH registry
Studies recruiting near Lincoln right now
Top 25 of 160 recruiting studies, sorted by proximity — each links to its official registry page
Secukinumab Open Label Roll-over Extension Protocol
Autoimmunity, Inflammation
Phase 4
Interventional 1,000 participants sought
Physician Research Collaboration — Lincoln, Nebraska (0.9 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
Nebraska Hematology Oncology /ID# 257710 — Lincoln, Nebraska (0.9 mi)
· Sponsor: AbbVie
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Bryan Heart — Lincoln, Nebraska (0.9 mi)
· Sponsor: Amgen
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)
Common Warts, Common Warts (Verruca Vulgaris)
Phase 3
Interventional 300 participants sought
Midwest Children's Health Research Institute — Lincoln, Nebraska (0.9 mi)
· Sponsor: Verrica Pharmaceuticals Inc.
Abbott Vascular Medical Device Registry
Acute Myocardial Infarction, Restenoses, Coronary
N/A
Observational 3,784 participants sought
Bryan Heart — Lincoln, Nebraska (0.9 mi)
· Sponsor: Abbott Medical Devices
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Cancer Partners of Nebraska — Lincoln, Nebraska (0.9 mi)
· Sponsor: Paradigm Health
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Cancer Partners of Nebraska ( Site 0068) — Lincoln, Nebraska (0.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Heart Failure
Phase 2
Interventional 620 participants sought
Velocity Clinical Research, Lincoln, Pioneer Heart Institute — Lincoln, Nebraska (0.9 mi)
· Sponsor: Pfizer
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
HER2-positive Breast Cancer, Breast Cancer
Phase 2
Interventional 125 participants sought
Cancer Partners of Nebraska — Lincoln, Nebraska (0.9 mi)
· Sponsor: Jazz Pharmaceuticals
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Schizophrenia, Bipolar I Disorder
Phase 3
Interventional 220 participants sought
Alkermes Investigator Site — Lincoln, Nebraska (0.9 mi)
· Sponsor: Alkermes, Inc.
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Lincoln, Nebraska (0.9 mi)
· Sponsor: TG Therapeutics, Inc.
Investigating the Effects of Beef Consumption on Cognitive and Brain Health
Dietary Intervention, Dietary Proteins
N/A
Interventional 240 participants sought
University of Nebraska-Lincoln — Lincoln, Nebraska (0.9 mi)
· Sponsor: University of Nebraska Lincoln
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Phase 3
Interventional 1,160 participants sought
Research Site — Lincoln, Nebraska (0.9 mi)
· Sponsor: AstraZeneca
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Allergy Asthma & Immunology- Site Number : 8400044 — Lincoln, Nebraska (0.9 mi)
· Sponsor: Sanofi
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
Solid Tumor, Adult
Phase 1, Phase 2
Interventional 348 participants sought
Nebraska Hematology Oncology — Lincoln, Nebraska (0.9 mi)
· Sponsor: Corbus Pharmaceuticals Inc.
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Velocity Clinical Research, Lincoln — Lincoln, Nebraska (0.9 mi)
· Sponsor: Sparrow Pharmaceuticals
ACP-204 in Adults With Alzheimer's Disease Psychosis
Alzheimer's Disease Psychosis
Phase 2, Phase 3
Interventional 1,074 participants sought
Alivation Research, LLC — Lincoln, Nebraska (0.9 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Schizophrenia, Bipolar Disorder
Phase 3
Interventional 300 participants sought
Alivation Research LLC — Lincoln, Nebraska (0.9 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Neoplasms, Gastrointestinal Neoplasms
Phase 3
Interventional 800 participants sought
Cancer Partners of Nebraska — Lincoln, Nebraska (0.9 mi)
· Sponsor: Pfizer
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Multiple Myeloma
Phase 3
Interventional 492 participants sought
Bryan Medical Center — Lincoln, Nebraska (0.9 mi)
· Sponsor: Pfizer
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Extensive-stage Small-cell Lung Cancer
Phase 3
Interventional 621 participants sought
Nebraska Hematology-Oncology (NHO) — Lincoln, Nebraska (0.9 mi)
· Sponsor: BioNTech SE
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Non-small Cell Lung Cancer
Phase 3
Interventional 310 participants sought
NHO Revive Research Institute LLC ( Site 0118) — Lincoln, Nebraska (0.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Saint Elizabeth Regional Medical Center — Lincoln, Nebraska (0.9 mi)
· Sponsor: NRG Oncology
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
Pneumococcal Disease
Phase 3
Interventional 1,200 participants sought
Midwest Children's Health Research Institute — Lincoln, Nebraska (0.9 mi)
· Sponsor: Pfizer
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Saint Elizabeth Regional Medical Center — Lincoln, Nebraska (0.9 mi)
· Sponsor: National Cancer Institute (NCI)